http://orcid.org/0000-0001-6827-0523
Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Yamaç Tekintaş & Aybala Temel. (2024) Antisense oligonucleotides: a promising therapeutic option against infectious diseases. Nucleosides, Nucleotides & Nucleic Acids 43:1, pages 1-39.
Read now
Read now
Zachary Boswell, Jacopo Umberto Verga, James Mackle, Karen Guerrero-Vazquez, Olivier P Thomas, James Cray, Bethany J Wolf, Yeun-Mun Choo, Peter Croot, Mark T Hamann & Gary Hardiman. (2023) In-Silico Approaches for the Screening and Discovery of Broad-Spectrum Marine Natural Product Antiviral Agents Against Coronaviruses. Infection and Drug Resistance 16, pages 2321-2338.
Read now
Read now
Mahmoud Kandeel. (2023) An overview of the recent progress in Middle East Respiratory Syndrome Coronavirus (MERS-CoV) drug discovery. Expert Opinion on Drug Discovery 18:4, pages 385-400.
Read now
Read now
Shuo Wang, Yujie Ren, Zhao Wang, Xiangyi Jiang, Shujing Xu, Xujie Zhang, Shujie Zhao, Waleed A Zalloum, Xinyong Liu & Peng Zhan. (2022) The current progress in the use of boron as a platform for novel antiviral drug design. Expert Opinion on Drug Discovery 17:12, pages 1329-1340.
Read now
Read now
Chavan Sakshi, A. Harikrishnan, Selvakumar Jayaraman, Ahana Roy Choudhury & V. Veena. (2022) Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections. Journal of Biomolecular Structure and Dynamics 40:11, pages 5175-5188.
Read now
Read now
Pasquale Pagliano, Carmine Sellitto, Giuliana Scarpati, Tiziana Ascione, Valeria Conti, Gianluigi Franci, Ornella Piazza & Amelia Filippelli. (2022) An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19). Expert Opinion on Drug Discovery 17:1, pages 9-18.
Read now
Read now
Juhi Sharma, Divakar Sharma, Dileep Tiwari & Vaishali Vishwakarma. (2021) The Challenges and Successes of Dealing with the COVID-19 Pandemic in India. Research and Reports in Tropical Medicine 12, pages 205-218.
Read now
Read now
Ran Chen, Tingting Wang, Jie Song, Daojun Pu, Dan He, Jianjun Li, Jie Yang, Kailing Li, Cailing Zhong & Jingqing Zhang. (2021) Antiviral Drug Delivery System for Enhanced Bioactivity, Better Metabolism and Pharmacokinetic Characteristics. International Journal of Nanomedicine 16, pages 4959-4984.
Read now
Read now
Abdul Hamid Arribathi, Ali Miftakhu Rosyad, Mukti Budiarto & Dedeh Supriyanti. (2021) An Analysis of Student Learning Anxiety During the COVID-19 Pandemic: A Study in Higher Education. The Journal of Continuing Higher Education 69:3, pages 192-205.
Read now
Read now
Muhammad Usama Ashraf, Sundas Sharif, Muhammad Usman Ahmad, Muhammad Nauman Zahid & Hamid Mukhtar. (2021) A review on clinical, pathological characteristics and drug designing for COVID-19. Arab Journal of Basic and Applied Sciences 28:1, pages 172-186.
Read now
Read now
Radostina Alexandrova, Pencho Beykov, Dobrin Vassilev, Marko Jukić & Črtomir Podlipnik. (2021) The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19. Biotechnology & Biotechnological Equipment 35:1, pages 74-102.
Read now
Read now
Concetta Cafiero, Agnese Re, Alessandra Micera, Raffaele Palmirotta, Delio Monaco, Francesca Romano, Claudia Fabrizio, Raffaele Di Francia, Andrea Cacciamani, Pier Luigi Surico, Gerardo D’Amato & Salvatore Pisconti. (2020) Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease. Pharmacogenomics and Personalized Medicine 13, pages 463-484.
Read now
Read now
Robert A Newman, K Jagannadha Sastry, Ravit Arav-Boger, Hongyi Cai, Rick Matos & Robert Harrod. (2020) Antiviral Effects of Oleandrin. Journal of Experimental Pharmacology 12, pages 503-515.
Read now
Read now
José Adão Carvalho Nascimento Junior, Anamaria Mendonça Santos, Lucindo José Quintans-Júnior, Cristiani Isabel Banderó Walker, Lysandro Pinto Borges & Mairim Russo Serafini. (2020) SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review. Expert Opinion on Therapeutic Patents 30:8, pages 567-579.
Read now
Read now
Abu Hazafa, Khalil ur-Rahman, Ikram-ul- Haq, Nazish Jahan, Muhammad Mumtaz, Muhammad Farman, Huma Naeem, Faheem Abbas, Muhammad Naeem, Sania Sadiqa & Saira Bano. (2020) The broad-spectrum antiviral recommendations for drug discovery against COVID-19. Drug Metabolism Reviews 52:3, pages 408-424.
Read now
Read now
Articles from other publishers (107)
Yifei Zhou & Xubo Lin. (2023) Binding kinetics of ten small-molecule drug candidates on SARS-CoV-2 3CLpro revealed by biomolecular simulations. Medicine in Novel Technology and Devices 20, pages 100257.
Crossref
Crossref
Haiyan Zhao, Hongfu He, Zhongjie Shen, Chunle Wei, Limin Yin, Yunying Zhu, Hongxia Lu, Runjiang Song & Deyu Hu. (2023) Development and Mechanism Investigation of Novel Thioacetalized Indoles as Antiphytoviral Agents. Journal of Agricultural and Food Chemistry 71:46, pages 17658-17668.
Crossref
Crossref
Rongxiu Huo, Xinxiang Huang & Jinying Lin. (2023) Mortality associated with Sjögren’s syndrome in the United States in the 1999–2020 period: A multiple cause-of-death study. Open Medicine 18:1.
Crossref
Crossref
Douglas Fraser-Pitt, Derry K. Mercer, Marie-Louise Francis, David Toledo-Aparicio, Daniel W. Smith & Deborah A. O'Neil. (2023) Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection. Biochemical and Biophysical Research Communications 677, pages 168-181.
Crossref
Crossref
Ghassan Mudher Hashim, Ghaidaa S. Hameed & Dalya Basil Hanna. (2023) The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs. Al Mustansiriyah Journal of Pharmaceutical Sciences 23:3, pages 231-249.
Crossref
Crossref
Martina Smolic, Reham Dawood, Ghada Salum, Mai Abd El Meguid, Moataza Omran & Robert Smolic. 2023. Post COVID-19 - Effects on Human Health. Post COVID-19 - Effects on Human Health.
ShaSha Xu, Zheng Niu, JingYi Zhang, Lixin Ren, Xiangyang Liu, ShuJuan Zhang, Hong Zou, Xia Hu, Jing Wang, Li Zhang, Yang Zhou & ZhenHui Song. (2023) Bioinformatic analysis of the S protein of human respiratory coronavirus. Molecular Phylogenetics and Evolution, pages 107704.
Crossref
Crossref
Lisa A. Beltz. 2023. Pathogenic Coronaviruses of Humans and Animals. Pathogenic Coronaviruses of Humans and Animals
125
172
.
Lisa A. Beltz. 2023. Pathogenic Coronaviruses of Humans and Animals. Pathogenic Coronaviruses of Humans and Animals
1
52
.
Pobitra Borah, Sangeeta Hazarika, Mohamed A. Morsy, Manoj Goyal, Ashna Chettri, Katharigatta N. Venugopala, Viresh Mohanlall, Pratap Chandra Acharya, Pran Kishore Deb & Raghu Prasad Mailavaram. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents
319
359
.
Dharshini Gopal, Sinosh Skariyachan & Govindappa Melappa. 2023. Functionalized Carbon Nanomaterials for Theranostic Applications. Functionalized Carbon Nanomaterials for Theranostic Applications
157
179
.
P. S. Akshay, S. Manasa Veena, Korra Bhanu Teja & Shilpa J. Tomar. 2023. Emerging Human Viral Diseases, Volume I. Emerging Human Viral Diseases, Volume I
157
187
.
Vikas Menon, Digvijay Pandey, Dishant Khosla, Mandheer Kaur, Harshit Kumar Vashishtha, A. Shaji George & Binay Kumar Pandey. 2023. IoT Based Smart Applications. IoT Based Smart Applications
1
13
.
Marina Shevachman, Abhirup Mandal, Kevin Gelston, Samir Mitragotri & Nitin Joshi. (2022) A Long‐Lasting Skin Protectant Based on CG‐101, a Deep Eutectic Solvent Comprising Choline and Geranic Acid. Global Challenges 6:11.
Crossref
Crossref
Abd. Kakhar Umar, James H. Zothantluanga, Keerthic Aswin, Saipul Maulana, Muhammad Sulaiman Zubair, H. Lalhlenmawia, Mithun Rudrapal & Dipak Chetia. (2022) Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, binding free energy calculations, and bioactivity prediction. Structural Chemistry 33:5, pages 1445-1465.
Crossref
Crossref
Cleber C. Melo-Filho, Tesia Bobrowski, Holli-Joi Martin, Zoe Sessions, Konstantin I. Popov, Nathaniel J. Moorman, Ralph S. Baric, Eugene N. Muratov & Alexander Tropsha. (2022) Conserved coronavirus proteins as targets of broad-spectrum antivirals. Antiviral Research 204, pages 105360.
Crossref
Crossref
Zhenfeng Wang, Shunshun Li & Bo Huang. (2022) Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Po-Chang Shih, Yi-Wen Mao, Jhe-Wei Hu, Han-Yi Hsieh, Tsai-Miao Shih, Lu-Ping Lu, Wei-Hua Chang, Chan-Hui Huang, Chia-Hung Lin, Chih-Hung Lin, Peng Tan, Ya-Ching Yang, Ming-Hong Chien, Chen-Che Su, Cheng-Hsin Yeh, Pei-Yun Chuang, Tien-Lan Hsieh, Ching-Cheng Wang, Po-Shiuan Hsieh, Teh-Ying Chou & Guochuan Emil Tsai. (2022) Development of Ultrapure and Potent Tannic Acids as a Pan-coronal Antiviral Therapeutic. ACS Pharmacology & Translational Science 5:6, pages 400-412.
Crossref
Crossref
Ran Zhang, Rick Oerlemans, Chao Wang, Lili Zhang & Matthew R. Groves. 2022. Drug Repurposing - Molecular Aspects and Therapeutic Applications. Drug Repurposing - Molecular Aspects and Therapeutic Applications.
Alberto Maria Cattaneo. (2022) Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus. Future Virology 17:6, pages 393-402.
Crossref
Crossref
Jin Tian, Jiumeng Sun, Dongyan Li, Ningning Wang, Lifang Wang, Chang Zhang, Xiaorong Meng, Xiang Ji, Marc A. Suchard, Xu Zhang, Alexander Lai, Shuo Su & Michael Veit. (2022) Emerging viruses: Cross-species transmission of coronaviruses, filoviruses, henipaviruses, and rotaviruses from bats. Cell Reports 39:11, pages 110969.
Crossref
Crossref
Shilei Zhang, Lulan Wang & Genhong Cheng. (2022) The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies. Molecular Therapy 30:5, pages 1869-1884.
Crossref
Crossref
Wael Hafez, Husam Saleh, Ziad Al Baha, Mishal Tariq, Samah Hamdan & Shougyat Ahmed. (2022) Antiviral Used among Non-Severe COVID-19 Cases in Relation to Time till Viral Clearance: A Retrospective Cohort Study. Antibiotics 11:4, pages 498.
Crossref
Crossref
Seyed Sajad Hosseini Balef, Zohreh Karimi, Aala Azari, Seyed Sadeq Sadraei, Parisa Hasanjani, Yasaman Sadeghi, Samin Ahmadi, Fateme Qorbannejad, Ali Farmoudeh & Hamid Irannejad. (2022) A Recent Update on the Clinical Trials and Effectiveness of Drugs Used in
COVID-19, MERS and SARS Coronaviruses. Anti-Infective Agents 20:2.
Crossref
Crossref
Abbas Al Mutair, Jinan Shamou, Saad Alhumaid, Laila Layqah, Gasmelseed Y. Ahmed, Koritala Thoyaja, Mohammed Al Mohaini, Sana Almahmoud, Mazin Barry, Amjad Khan, Kuldeep Dhama, Lamiaa Hamad Al-Jamea, Alxeander Woodman & Ali A. Rabaan. (2022) Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia. Journal of Infection and Public Health 15:4, pages 389-394.
Crossref
Crossref
Dongzhi Li, Chengshuai He, Meizi Wang, Hongyu Liu, Runqiang Liu & Li Xu. (2022)
Toxicity of Ribavirin to
Spodoptera litura
by Inhibiting the Juvenile Hormone
. Journal of Agricultural and Food Chemistry 70:10, pages 3117-3126.
Crossref
Crossref
Nasim Shahhamzehei, Sara Abdelfatah & Thomas Efferth. (2022) In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library. Pharmaceuticals 15:3, pages 308.
Crossref
Crossref
Saba Hasan, Manish Dwivedi, Sutanu Mukhopadhyay & Nandini Gupta. (2022) Landscape Determinants of Infectivity and Insights into Vaccine Development
and Effectiveness - Novel Coronavirus. Letters in Drug Design & Discovery 20:2, pages 119-143.
Crossref
Crossref
Chia‐Chuan Cho, Shuhua G. Li, Tyler J. Lalonde, Kai S. Yang, Ge Yu, Yuchen Qiao, Shiqing Xu & Wenshe Ray Liu. (2021) Drug Repurposing for the SARS‐CoV‐2 Papain‐Like Protease. ChemMedChem 17:1.
Crossref
Crossref
Aline Yen Ling Wang. (2022) Modified mRNA-Based Vaccines Against Coronavirus Disease 2019. Cell Transplantation 31, pages 096368972210902.
Crossref
Crossref
Poppy O. Smith, Peiqin Jin & Khondaker Miraz Rahman. (2022) Strategies for drug repurposing against coronavirus targets. Current Research in Pharmacology and Drug Discovery 3, pages 100072.
Crossref
Crossref
Raghvendra Dubey & Kushagra Dubey. 2022. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention. Modeling, Control and Drug Development for COVID-19 Outbreak Prevention
203
244
.
Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi, Yuchen Sun, Christian Brueffer, Jeffrey M. Field, Marouen Ben Guebila, Nafisa M. Jadavji, Ashwin N. Skelly, Bharath Ramsundar, Jinhui Wang, Rishi Raj Goel, YoSon Park, Simina M. Boca, Anthony Gitter & Casey S. Greene. (2021) Identification and Development of Therapeutics for COVID-19. mSystems 6:6.
Crossref
Crossref
Mayank Kapoor, Prasan Kumar Panda & Vivek Mohanty. 2021. Fighting the COVID-19 Pandemic. Fighting the COVID-19 Pandemic.
M. A. Kharitonov, V. V. Salukhov, E. V. Kryukov, M. B. Patsenko, Yu. V. Rudakov, A. B. Bogomolov, V. V. Ivanov & A. A. Minakov. (2021) Viral pneumonia: a new look at an old problem (review). Meditsinskiy sovet = Medical Council:16, pages 60-77.
Crossref
Crossref
Kiarash Saleki, Shakila Yaribash, Mohammad Banazadeh, Ehsan Hajihosseinlou, Mahdi Gouravani, Amene Saghazadeh & Nima Rezaei. (2021) Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies. European Journal of Pharmacology 906, pages 174248.
Crossref
Crossref
Nils von Hentig. (2021) Repositioning HIV protease inhibitors and nucleos(t)ide RNA polymerase inhibitors for the treatment of SARS-CoV-2 infection and COVID-19. European Journal of Clinical Pharmacology 77:9, pages 1297-1307.
Crossref
Crossref
Arianna Calistri, Anna Luganini, Barbara Mognetti, Elizabeth Elder, Giulia Sibille, Valeria Conciatori, Claudia Del Vecchio, Stefano Sainas, Donatella Boschi, Nuria Montserrat, Ali Mirazimi, Marco Lucio Lolli, Giorgio Gribaudo & Cristina Parolin. (2021) The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses. Microorganisms 9:8, pages 1731.
Crossref
Crossref
Setayesh Yazdani, Nicola De Maio, Yining Ding, Vijay Shahani, Nick Goldman & Matthieu Schapira. (2021) Genetic Variability of the SARS-CoV-2 Pocketome. Journal of Proteome Research 20:8, pages 4212-4215.
Crossref
Crossref
Moudhi Almutlaq, Abir Abdullah Alamro, Fayhan Alroqi & Tlili Barhoumi. (2021) Classical and Counter-Regulatory Renin–Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology. CJC Open 3:8, pages 1060-1074.
Crossref
Crossref
Berta CanalAllison W. McClureJoseph F. CurranMary WuRachel UlfertsFlorian WeissmannJingkun ZengAgustina P. BertolinJennifer C. MilliganSouradeep BasuLucy S. DruryTom D. DeeganRyo FujisawaEmma L. RobertsClovis BasierKarim Labib, Rupert BealeMichael HowellJohn F.X. Diffley. (2021) Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease. Biochemical Journal 478:13, pages 2445-2464.
Crossref
Crossref
Betsy Yang & Kuender D. Yang. (2021) Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention. Frontiers in Immunology 12.
Crossref
Crossref
Fengming Liu, Kun Han, Robert Blair, Kornelia Kenst, Zhongnan Qin, Berin Upcin, Philipp Wörsdörfer, Cecily C. Midkiff, Joseph Mudd, Elizaveta Belyaeva, Nicholas S. Milligan, Tyler D. Rorison, Nicole Wagner, Jochen Bodem, Lars Dölken, Bertal H. Aktas, Richard S. Vander Heide, Xiao-Ming Yin, Jay K. Kolls, Chad J. Roy, Jay Rappaport, Süleyman Ergün & Xuebin Qin. (2021) SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Brahmaiah Pendyala, Ankit Patras & Chandravanu Dash. (2021) Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study. Frontiers in Microbiology 12.
Crossref
Crossref
Chong-Hyun Shin, Ki-Hye Kim, Subbiah Jeeva & Sang-Moo Kang. (2021) Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 10:6, pages 1412.
Crossref
Crossref
Mark Laws, Yasmin M. Surani, Md. Mahbub Hasan, Yiyuan Chen, Peiqin Jin, Taha Al-Adhami, Madiha Chowdhury, Aqeel Imran, Ioannis Psaltis, Shirin Jamshidi, Kazi S. Nahar & Khondaker Miraz Rahman. (2021) Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19. Current Medicinal Chemistry 28:19, pages 3803-3824.
Crossref
Crossref
X. Jiang, Z. Li, D.J. Young, M. Liu, C. Wu, Y.-L. Wu & X.J. Loh. (2021) Toward the prevention of coronavirus infection: what role can polymers play?. Materials Today Advances 10, pages 100140.
Crossref
Crossref
Akbar Noorbakhsh, Rafee Habib Askandar, Mohammad Shakib Alhagh, Chiako Farshadfar, Seyed Hamid Seyedi, Mehran Ahmadizad, Arian Rahimi, Noeman Ardalan & Elnaz Hosseininezhadian Koushki. (2021) Prevention of SARS-CoV-2 Proliferation with a Novel and Potent Main Protease Inhibitor by Docking, ADMET, MM-PBSA, and Molecular Dynamics Simulation. Journal of Computational Biophysics and Chemistry 20:03, pages 305-322.
Crossref
Crossref
D. Lacavalla, G. Santandrea, D. Andreotti, R. Stano & S. Occhionorelli. (2021) Case report of gastrointestinal localization of SARS-CoV-2 and open abdomen technique in an Italian emergency surgery department for gastrointestinal bleeding. Annals of Medicine and Surgery, pages 102405.
Crossref
Crossref
Abdullah SARMAN, Suat TUNCAY & Emine SARMAN. (2021) Diagnosis of Covid-19 in Children and Nursing Approach: A Systematic ReviewÇocuklarda Covid-19’un Tanılanmasında Hemşirelik Yaklaşımı: Sistematik Bir İnceleme. Acta Medica Alanya 5:1, pages 98-106.
Crossref
Crossref
Abdullah Sarman & Suat Tuncay. (2020) Principles of approach to suspected or infected patients related Covid‐19 in newborn intensive care unit and pediatric intensive care unit. Perspectives in Psychiatric Care 57:2, pages 957-964.
Crossref
Crossref
Chongyi Li, Zhao Geng, Bo Yang, He Xiao, Zhiqiang Wang & Jian Ye. (2021) Serum Aβ Levels are Associated with Age-related Cataract. Neurotoxicity Research 39:2, pages 369-377.
Crossref
Crossref
Catherine S. Adamson, Kelly Chibale, Rebecca J. M. Goss, Marcel Jaspars, David J. Newman & Rosemary A. Dorrington. (2021) Antiviral drug discovery: preparing for the next pandemic. Chemical Society Reviews 50:6, pages 3647-3655.
Crossref
Crossref
David Caldevilla-Domínguez, Almudena Barrientos-Báez & Graciela Padilla-Castillo. (2021) Twitter as a Tool for Citizen Education and Sustainable Cities after COVID-19. Sustainability 13:6, pages 3514.
Crossref
Crossref
Sergei D. Bakharev, Elena V. Baulo, Svetlana V. Bykova, Saria R. Dbar & Asfold I. Parfenov. (2021) COVID-19 and the small intestine. Terapevticheskii arkhiv 93:3, pages 343-347.
Crossref
Crossref
Shuang Wang, Qiang Zhang, Peng Wang, Huahong Ye, Xiaoqing Jing, Zhongdan Zhang, Shisheng Zhu, Tingting Luo & Zhaobin Zheng. (2021) Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China. Open Medicine 16:1, pages 367-374.
Crossref
Crossref
Michelli dos Santos, André V.F. Ferreira, Jonatas O. da Silva, Laís M. Nogueira, Juliana M. Machado, Mariana F.C. Francisco, Mariana C. da Paz, Rodolfo C. Giunchetti & Alexsandro S. Galdino. (2021) Patents Related to Pathogenic Human Coronaviruses. Recent Patents on Biotechnology 15:1, pages 12-24.
Crossref
Crossref
Rossana Segreto & Yuri Deigin. (2020) The genetic structure of SARS‐CoV‐2 does not rule out a laboratory origin. BioEssays 43:3.
Crossref
Crossref
Christoph Gorgulla, Krishna M. Padmanabha Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zi-Fu Wang, Guilhem Tesseyre, Shreya Pandita, Alec Shnapir, Anthony Calderaio, Minko Gechev, Alexander Rose, Noam Lewis, Colin Hutcheson, Erez Yaffe, Roni Luxenburg, Henry D. Herce, Vedat Durmaz, Thanos D. Halazonetis, Konstantin Fackeldey, J.J. Patten, Alexander Chuprina, Igor Dziuba, Alla Plekhova, Yurii Moroz, Dmytro Radchenko, Olga Tarkhanova, Irina Yavnyuk, Christian Gruber, Ryan Yust, Dave Payne, Anders M. Näär, Mark N. Namchuk, Robert A. Davey, Gerhard Wagner, Jamie Kinney & Haribabu Arthanari. (2021) A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. iScience 24:2, pages 102021.
Crossref
Crossref
Oliver W. L. Carter, Yingjian Xu & Peter J. Sadler. (2021) Minerals in biology and medicine. RSC Advances 11:4, pages 1939-1951.
Crossref
Crossref
Jin-Hong Yoo. (2021) What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. Journal of Korean Medical Science 36:6.
Crossref
Crossref
Kawthar Mohamed, Niloufar Yazdanpanah, Amene Saghazadeh & Nima Rezaei. (2021) Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review. Bioorganic Chemistry 106, pages 104490.
Crossref
Crossref
R. C. Sobti, Bharti Kotarya, Abhishek Pandeya, Raj Kumar Khalko, Neelam Yadav, Sudipta Saha, Y. Vasudeva Rao & Sunil Babu Gosipatala. 2021. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications
1
40
.
Tianguang Huang, Lin Sun, Dongwei Kang, Vasanthanathan Poongavanam, Xinyong Liu, Peng Zhan & Luis Menéndez-Arias. 2021. Antiviral Drug Discovery and Development. Antiviral Drug Discovery and Development
219
260
.
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi & Mattia Mori. (2020) Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge. Molecules 25:23, pages 5695.
Crossref
Crossref
Mulugeta Kiros, Henok Andualem, Teklehaimanot Kiros, Wasihun Hailemichael, Sisay Getu, Alene Geteneh, Derbie Alemu & Woldaregay Erku Abegaz. (2020) COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission. Virology Journal 17:1.
Crossref
Crossref
Xinbin Zhao, Yuecheng Ding, Jing Du & Yubo Fan. (2020) 2020 update on human coronaviruses: One health, one world. Medicine in Novel Technology and Devices 8, pages 100043.
Crossref
Crossref
Anna Artese, Valentina Svicher, Giosuè Costa, Romina Salpini, Velia Chiara Di Maio, Mohammad Alkhatib, Francesca Alessandra Ambrosio, Maria Mercedes Santoro, Yehuda G. Assaraf, Stefano Alcaro & Francesca Ceccherini-Silberstein. (2020) Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resistance Updates 53, pages 100721.
Crossref
Crossref
Lígia N de M Ribeiro & Belchiolina B Fonseca. (2020) The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic. Future Microbiology 15:16, pages 1571-1582.
Crossref
Crossref
Daniel P. Cashman. (2020) Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease. Medical Hypotheses 144, pages 110027.
Crossref
Crossref
Sarah Lam, Andrew Lombardi & Aviv Ouanounou. (2020) COVID-19: A review of the proposed pharmacological treatments. European Journal of Pharmacology 886, pages 173451.
Crossref
Crossref
Emanuella Dutra Gonçalves, Ana Luisa Marossi Justiniano, Camila de Carvalho e Freitas, Éttore Eduardo Simensato Abrame, João Remesso Ferreira Reinaldi & Laura Ribeiro de Matos. (2020) Farmacoterapia aplicada à COVID-19. Revista Científica Multidisciplinar Núcleo do Conhecimento, pages 58-81.
Crossref
Crossref
Matthew C Morris, Cole A Lyman, Spencer Richman, Hong Bao Cao, Chris Cheadle & Gordon Broderick. (2020) Predicting the Immune Response to Repurposed Drugs in Coronavirus-induced Cytokine Storm. Predicting the Immune Response to Repurposed Drugs in Coronavirus-induced Cytokine Storm.
Pablo F. Garrido, Martín Calvelo, Alexandre Blanco-González, Uxía Veleiro, Fabián Suárez, Daniel Conde, Alfonso Cabezón, Ángel Piñeiro & Rebeca Garcia-Fandino. (2020) The Lord of the NanoRings: Cyclodextrins and the battle against SARS-CoV-2. International Journal of Pharmaceutics 588, pages 119689.
Crossref
Crossref
Xiaoyan Pan, Pengfei Zhou, Tiejiong Fan, Yan Wu, Jing Zhang, Xiaoyue Shi, Weijuan Shang, Lijuan Fang, Xiaming Jiang, Jian Shi, Yuan Sun, Shaojuan Zhao, Rui Gong, Ze Chen & Gengfu Xiao. (2020) Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro. Antiviral Research 182, pages 104868.
Crossref
Crossref
Markus Zeitlinger, Birgit C. P. Koch, Roger Bruggemann, Pieter De Cock, Timothy Felton, Maya Hites, Jennifer Le, Sonia Luque, Alasdair P. MacGowan, Deborah J. E. Marriott, Anouk E. Muller, Kristina Nadrah, David L. Paterson, Joseph F. Standing, João P. Telles, Michael Wölfl-Duchek, Michael Thy & Jason A. Roberts. (2020) Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents. Clinical Pharmacokinetics 59:10, pages 1195-1216.
Crossref
Crossref
Siddhi Joshi, Maithili Joshi & Mariam S Degani. (2020) Tackling SARS-CoV-2: proposed targets and repurposed drugs. Future Medicinal Chemistry 12:17, pages 1579-1601.
Crossref
Crossref
Gonzalo Segrelles-Calvo, Glauber R de S Araújo & Susana Frases. (2020) Systemic mycoses: a potential alert for complications in COVID-19 patients. Future Microbiology 15:14, pages 1405-1413.
Crossref
Crossref
Y. Cen, X. Chen, Y. Shen, X.-H. Zhang, Y. Lei, C. Xu, W.-R. Jiang, H.-T. Xu, Y. Chen, J. Zhu, L.-L. Zhang & Y.-H. Liu. (2020) Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study. Clinical Microbiology and Infection 26:9, pages 1242-1247.
Crossref
Crossref
John G. Rizk, Kamyar Kalantar-Zadeh, Mandeep R. Mehra, Carl J. Lavie, Youssef Rizk & Donald N. Forthal. (2020) Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs 80:13, pages 1267-1292.
Crossref
Crossref
Elena Cabezón & Ignacio Arechaga. (2020) Drug Weaponry to Fight Against SARS-CoV-2. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Athri D. Rathnayake, Jian Zheng, Yunjeong Kim, Krishani Dinali Perera, Samantha MackinDavid K. Meyerholz, Maithri M. Kashipathy, Kevin P. Battaile, Scott Lovell, Stanley Perlman, William C. Groutas & Kyeong-Ok Chang. (2020) 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice. Science Translational Medicine 12:557.
Crossref
Crossref
Igor de Andrade Santos, Victória Riquena Grosche, Fernando Rodrigues Goulart Bergamini, Robinson Sabino-Silva & Ana Carolina Gomes Jardim. (2020) Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?. Frontiers in Microbiology 11.
Crossref
Crossref
Linzi Fan, Shuang Jiang, Xinrong Yang, Zhibin Wang & Chunjuan Yang. (2020) COVID-19 Drug Treatment in China. Current Pharmacology Reports 6:4, pages 146-154.
Crossref
Crossref
Amit Kumar Gupta, Md. Shoaib Khan, Shubham Choudhury, Adhip Mukhopadhyay, Sakshi, Amber Rastogi, Anamika Thakur, Pallawi Kumari, Manmeet Kaur, Shalu, Chanchal Saini, Vandna Sapehia, Barkha, Pradeep Kumar Patel, Kailash T. Bhamare & Manoj Kumar. (2020) CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2. Frontiers in Microbiology 11.
Crossref
Crossref
Mukarram Jamat Ali, Muhammad Hanif, Muhammad Adnan Haider, Muhammad Umer Ahmed, FNU Sundas, Arham Hirani, Izhan Ali Khan, Khurram Anis & Amin H. Karim. (2020) Treatment Options for COVID-19: A Review. Frontiers in Medicine 7.
Crossref
Crossref
Syamsudin Abdillah & Yatnita Parama Cita. (2020) Potential target plants as anti- sars-cov-2 (Coronavirus): Expectations and challenges. Indian Journal of Pharmacy and Pharmacology 7:2, pages 57-65.
Crossref
Crossref
Petra Krafcikova, Jan Silhan, Radim Nencka & Evzen Boura. (2020) Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. Nature Communications 11:1.
Crossref
Crossref
Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk & Hans-Peter Deigner. (2020) COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks. International Journal of Molecular Sciences 21:14, pages 4953.
Crossref
Crossref
KA Al-Anazi & AM Al-Jasser. (2020) The rising role of mesenchymal stem cells in the treatment of COVID-19 infections. Journal of Stem Cell Therapy and Transplantation 4:1, pages 011-016.
Crossref
Crossref
Jin Zhou & Jie Huang. (2020) Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Alejandro Llanes, Carlos M. Restrepo, Zuleima Caballero, Sreekumari Rajeev, Melissa A. Kennedy & Ricardo Lleonart. (2020) Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic. International Journal of Molecular Sciences 21:12, pages 4546.
Crossref
Crossref
Cristiano Conte, Francesco Sogni, Paola Affanni, Licia Veronesi, Alberto Argentiero & Susanna Esposito. (2020) Vaccines against Coronaviruses: The State of the Art. Vaccines 8:2, pages 309.
Crossref
Crossref
Felician Stancioiu, Georgios Papadakis, Stelios Kteniadakis, Boris Izotov, Michael Coleman, Demetrios Spandidos & Aristidis Tsatsakis. (2020) A dissection of SARS‑CoV2 with clinical implications (Review). International Journal of Molecular Medicine 46:2, pages 489-508.
Crossref
Crossref
Joaquim Bosch-Barrera, Begoña Martin-Castillo, Maria Buxó, Joan Brunet, José Antonio Encinar & Javier A. Menendez. (2020) Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients. Journal of Clinical Medicine 9:6, pages 1770.
Crossref
Crossref
Juhi Jain, Sharad Gaur, Yash Chaudhary & Rajeev Kaul. (2020) The molecular biology of intracellular events during Coronavirus infection cycle. VirusDisease 31:2, pages 75-79.
Crossref
Crossref
Youwen Mei, Dan Luo, Sumei Wei, Xiaoyan Liao, Yue Pan, Xiao Yang & Yonghong Lin. (2020) Obstetric Management of COVID-19 in Pregnant Women. Frontiers in Microbiology 11.
Crossref
Crossref
José Antonio Encinar & Javier A. Menendez. (2020) Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA. Viruses 12:5, pages 525.
Crossref
Crossref
Xiangyang Xie, Yuanliang Jiang, Yuan Zeng & Hui Liu. (2019) Combination Antiviral Therapy with Lopinavir/Ritonavir, Arbidol and Interferon-α1b for COVID-19. Antiviral Therapy 25:4, pages 233-239.
Crossref
Crossref
Thomas Hanscheid, Emília Valadas & Martin P. Grobusch. (2020) Coronavirus 2019-nCoV: Is the genie already out of the bottle?. Travel Medicine and Infectious Disease 35, pages 101577.
Crossref
Crossref
Suliman Khan, Rabeea Siddique, Muhammad Adnan Shereen, Ashaq Ali, Jianbo Liu, Qian Bai, Nadia Bashir & Mengzhou Xue. (2020) Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. Journal of Clinical Microbiology 58:5.
Crossref
Crossref
Jianhui Wang, Hongbo Qi, Lei Bao, Fang Li & Yuan Shi. (2020) A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units. The Lancet Child & Adolescent Health 4:4, pages 258-259.
Crossref
Crossref
João Trigueiro-Louro, Vanessa Correia, Inês Figueiredo-Nunes, Marta Gíria & Helena Rebelo-de-Andrade. (2020) Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike. Computational and Structural Biotechnology Journal 18, pages 2117-2131.
Crossref
Crossref
Vimal K. Maurya, Swatantra Kumar, Madan L. B. Bhatt & Shailendra K. Saxena. 2020. Coronavirus Disease 2019 (COVID-19). Coronavirus Disease 2019 (COVID-19)
109
126
.
Matilde Hoffman, DeGaulle I. Chigbu, Brenndan L. Crumley, Ravi Sharma, Sergey Pustylnikov, Thomas Crilley, Rashida Ginwala, Ronak Loonawat, Julie Joseph, Dominic Sales, Sydney Wilson & Pooja Jain. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control
1
120
.
Maged Gomaa Hemida. (2019) Middle East Respiratory Syndrome Coronavirus and the One Health concept. PeerJ 7, pages e7556.
Crossref
Crossref
Niccolo Leo Caldararo. (2020) COVID-19: History of Disease Avoidance, Social Spacing and Work/Home Matrix. SSRN Electronic Journal.
Crossref
Crossref